Amends existing law to provide that pharmacists may make certain prescriptions as authorized by rule of the Board of Pharmacy.

This bill amends the definition of the practice of pharmacy to increase patient access to certain categories of medications that are low risk, if used under the supervision of a pharmacist. Specifically, it would allow the Board of Pharmacy to designate by rule products that patients may obtain directly from a pharmacist for conditions that do not require a diagnosis, conditions that are minor and self-limiting, and conditions that have a simple CLIA-waived laboratory test which guides clinical decision making. Other states have been able to achieve improved health outcomes and lowered overall healthcare costs from similar policies.